Vaccine Therapy in Treating Patients With Unresected Stage III or Stage IV Melanoma
Completed · Phase 2
Conditions studied: Melanoma (Skin)
In brief
RATIONALE: Vaccines made from a person's white blood cells and a donor's tumor cells may help the body build an effective immune response to kill tumor cells. PURPOSE: This phase II trial is studying how well vaccine therapy works in treating patients with unresected stage III or stage IV melanoma.
Key facts
- Study ID
- NCT00107159
- Run by
- Jonsson Comprehensive Cancer Center
- People needed
- 37
- Starts
- 2005-01-01
- Expected to finish
- 2010-09-01
- Last updated by the study team
- 2013-11-06
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Jonsson Comprehensive Cancer Center at UCLA — Los Angeles, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.